UA97044C2 - Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases - Google Patents

Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases

Info

Publication number
UA97044C2
UA97044C2 UAA201011083A UAA201011083A UA97044C2 UA 97044 C2 UA97044 C2 UA 97044C2 UA A201011083 A UAA201011083 A UA A201011083A UA A201011083 A UAA201011083 A UA A201011083A UA 97044 C2 UA97044 C2 UA 97044C2
Authority
UA
Ukraine
Prior art keywords
antiviral
agent
prevention
preparation
treatment
Prior art date
Application number
UAA201011083A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александр Викторович Доровский
Геннадий Геннадиевич Хорунжий
Original Assignee
Общество С Ограниченной Ответственностью «Фармацевтическая Группа «Здоровье»
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью «Фармацевтическая Группа «Здоровье» filed Critical Общество С Ограниченной Ответственностью «Фармацевтическая Группа «Здоровье»
Priority to UAA201011083A priority Critical patent/UA97044C2/en
Priority to RU2010142333/15A priority patent/RU2010142333A/en
Priority to EA201171014A priority patent/EA201171014A1/en
Publication of UA97044C2 publication Critical patent/UA97044C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to medicine, in particular to pharmacology, and concerns an agent of antiviral and immunopotentiating activity comprising 1-methyl-2-((phenylthio)methyl)-3-carbethoxy-4-((dimethylamino)methyl)-5-hydroxy-6-bromoindole hydrochloride monohydrate as an active substance and pharmaceutically acceptable adjuvants.
UAA201011083A 2010-09-15 2010-09-15 Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases UA97044C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
UAA201011083A UA97044C2 (en) 2010-09-15 2010-09-15 Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases
RU2010142333/15A RU2010142333A (en) 2010-09-15 2010-10-18 MEANS OF ANTIVIRAL AND IMMUNITY OF MULTI-ACTIVITY, METHOD OF PRODUCING ANTIVIRAL AND IMMUNITY OF MULTI-ACTIVITY, METHOD OF PREVENTION AND TREATMENT OF INFECTIOUS DISEASES
EA201171014A EA201171014A1 (en) 2010-09-15 2011-09-05 MEANS OF ANTI-VIRUS AND IMMUNATORATIVE ACTIVITY, METHOD OF OBTAINING MEANS OF ANTI-VIRUS AND IMMUNOSATING ACTIVITY, METHOD OF PREVENTION AND TREATMENT OF INFECTIOUS DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201011083A UA97044C2 (en) 2010-09-15 2010-09-15 Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases

Publications (1)

Publication Number Publication Date
UA97044C2 true UA97044C2 (en) 2011-12-26

Family

ID=45908258

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201011083A UA97044C2 (en) 2010-09-15 2010-09-15 Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases

Country Status (3)

Country Link
EA (1) EA201171014A1 (en)
RU (1) RU2010142333A (en)
UA (1) UA97044C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112933061B (en) * 2021-02-22 2022-08-09 石家庄四药有限公司 Arbidol hydrochloride capsule and preparation method thereof

Also Published As

Publication number Publication date
EA201171014A1 (en) 2012-03-30
RU2010142333A (en) 2012-04-27

Similar Documents

Publication Publication Date Title
MX2012012438A (en) Pharmaceutical formulations comprising pioglitazone and linagliptin.
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
IN2012DN02805A (en)
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
MX2014002171A (en) Combination treatments for hepatitis c.
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
EA017091B9 (en) Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
JO3122B1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
MX2010009624A (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1.
EP2722042A4 (en) Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
MX2012002681A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units.
IN2014DN01619A (en)
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
JO3587B1 (en) Oral dosage forms of bendamustine
MX2013007661A (en) Phenyl-isoxazol derivatives and preparation process thereof.
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
GB2446341A (en) Method and system for transdermal drug delivery
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX2008011020A (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor.
IN2014MN02156A (en)
IL195062A0 (en) Process for the preparation of solid sterile active pharmaceutical ingredient